Monopar Therapeutics(MNPR) - 2024 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K | Delaware | 001-39070 | 32-0463781 | | --- | --- | --- | | (State or other jurisdiction | (Commission | (I.R.S. Employer | | of incorporation) | File Number) | Identification No.) | 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091 (Address of principal executive offices) (Zip Code) (847) 388-0349 Registrant's telephone number, including area code CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of ...